Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crestor in children and adolescents with heterozygous familial hypercholesterolemia
NCT00355615Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2006
- Primary completion
- Jul 2008
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of rosuvastatin in heterozygous familial hypercholesterolemia (HeFH), sponsored by AstraZeneca. Started Jul 2006; status: completed.
02
Drugs
rosuvastatin
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT00355615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355615.